Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicamen Biotech Ltd. Major Shareholding Notification 2021

Dec 29, 2021

61898_rns_2021-12-29_cf5a0ce4-0d3d-420b-a654-ee82a6818040.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

EDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)

Tel.: 011 - 47589500-51 (50 Lines), E-mail: [email protected] Web: www.medicamen.com CIN No.: L74899DL1993PLC056594

Dated: 29.12.2021

To. BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001

National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

Scrip Code: 531146

Subject: Intimation as per Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam.

Please find attached disclosure dated December 29, 2021 in Form-C pursuant to Regulation $7(2)(a)$ read with Regulation $6(2)$ of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Growel Remedies Limited for sale of 46,010 Equity Shares from the open market.

We request you to treat this intimation as compliance with Regulation $7(2)$ (b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and take the same on record.

For Medicamen Biotech Limited 'ò E

Parul Choudhary Company Secretary ACS: 44157

Encl: A/a

Dated: 29.12.2021

To, The Compliance Officer Medicamen Biotech Limited 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, 110019

Subject: Submission of disclosure under Regulation $7(2)(a)$ read with regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015

Dear Sir/Madam,

With reference to the above captioned subject, we would like to apprise you that Growel Remedies Limited (Promoter of Medicamen Biotech Limited ("Target Company") has sold 46,010 Equity Shares of Rs. 10/- each through the open market.

In this connection please find enclosed the required disclosure.

You are requested to take the above information on your records and inform the exchange accordingly.

For Growel Remedies Limited Ashwani Kumar Sharma Director DIN: 00325634

Encl: A/a

Name of the company: Medicamen Biotech Limited ISIN of the company: INE646B01010

[Regulation 7 (2) read with Regulation $6(2) -$ Continual disclosure] SEBI (Prohibition of Insider Trading) Regulations, 2015 FORM C

$\overline{\phantom{a}}$

$\ddot{\phantom{0}}$

$\overline{1}$

Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other
such persons as mentioned in Regul

market/public
acquisition /
disposal (on
preferential
Mode of
rights/
market/ Inter-
offer / off
transfer.
ESOP S
etc.)
Se
E
pay
On Market
Ò
OMO
intimation
company
Date of
$\overline{c}$
29.12.2021
disposal of shares
Date of allotment
acquisition of
advice/
specify
shares/
Гo 28.12.2021
From 27.12.2021
aequisition/disposal
Securities held post
shareholding
No. and %
$\sigma$
equity shares
$(2.08\%)$
2.53.990
Debenture
s Rights
Convertib
(For eg-
Warrants.
entitleme
Type of
security
Shares,
nt. etc.)
$\overline{e}$
Equity
Shares
Securities aequired/Disposed (Purchase
Invocatio
Transact
Revocati
specify)
Others
Pledge
please
Type
/sale
$\overline{\text{ion}}$
$\ddagger$
$\pm$
Sale
Value (In Rs.) Forty Four thousand
Rupees Four Crore
Seventy One Paise
Rs. 4.54,44,459.71
Four Hundred and
Four Lakhs
Fifty Nine and
$only(-)$
Note: "Securities" shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015
$\circ$
Z.
46.010
Equity
Shares
(For eg.
Converti
Warrant
Debentu
etc.)etc.)
Type of
security
Rights
entitlem
Shares.
ents
res
ble
$\ddot{s}$
Equity
Shares
aequisition/disposal
Securities held
prior to
sharehold
and $\frac{0}{6}$
Σò.
$\overline{\Xi}$
$\overline{\mathrm{of}}$
3.00.000
equity
shares
$(2.46\%)$
entitlements
Convertible
Debentures
Warrants.
- Shares,
Type of
security
(For eg.
Rights
etc.)
Equity shares
of
Category of
s/immediate
group/desig
(Promoter/
promoter
member
to/others
Director
relative
person/
Person
nated
etc.)
the
Promoter
(dno.fa)
& address
CIN/DIN
contact
Name.
PAN.
with
nos.
Growel Wellness
Innovations Ltd.)
$\frac{\text{Constant}}{+919810739079}$
Tower.43. Nehru
Address: 1506.
Name: Growel
AABCG3108P
Place. New
Delhi-110019
Remedies
(formerly
Chiranjiv
Contact
Limited
PAN:

Exchange on which the trade was Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2). executed Number of units Sell Notional Value Trading in derivatives (Specify type of contract, Futures or Options etc) Number of units (contracts * lot $\overline{Bu}y$ Notional Value specifications Contract Type of contract

$\overline{a}$

Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options.

X

$\frac{1}{2}$

$\frac{1}{2}$

$\frac{1}{2}$

$\frac{1}{2}$

NA

size) X

(contracts * lot size)

Yours faithfully

For Growel Remedies Ltd

median

ISWC Ashwani Kumar Sharma

Limi

DIN: 00325634 Director

Place: New Delhi Date: 29.12.2021

*******